MD3717G2 - Metodă de diagnostic diferenţiat al tumorilor glandei mamare - Google Patents

Metodă de diagnostic diferenţiat al tumorilor glandei mamare Download PDF

Info

Publication number
MD3717G2
MD3717G2 MDA20080082A MD20080082A MD3717G2 MD 3717 G2 MD3717 G2 MD 3717G2 MD A20080082 A MDA20080082 A MD A20080082A MD 20080082 A MD20080082 A MD 20080082A MD 3717 G2 MD3717 G2 MD 3717G2
Authority
MD
Moldova
Prior art keywords
gsh
ggt
gst
g6pdh
saliva
Prior art date
Application number
MDA20080082A
Other languages
English (en)
Russian (ru)
Other versions
MD3717F1 (ro
Inventor
Людмила ГАВРИЛЮК
Надежда ГОДОРОЖА
Наталия БОТНАРЮК
Анна ВАРТИЧАН
Original Assignee
Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова filed Critical Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова
Priority to MDA20080082A priority Critical patent/MD3717G2/ro
Publication of MD3717F1 publication Critical patent/MD3717F1/ro
Publication of MD3717G2 publication Critical patent/MD3717G2/ro

Links

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Invenţia se referă la medicină, şi anume la biochimia clinică şi poate fi utilizată pentru diagnosticarea diferenţiată a hiperplaziilor dishormonale şi a cancerului glandei mamare.Esenţa invenţiei constă în aceea că se determină conţinutul glutationului redus (GSH), activitatea glutation-S-transferazei (GST), glutationreductazei (GR), gama-glutamiltranspeptidazei (GGT) şi glucozo-6-fosfatdehidrogenazei (G6PDH) în plasma sângelui şi în salivă, se calculează raporturile GR/G6PDH, GR/GST, GR/GGT şi GR/GSH şi în cazul în care în plasmă se determină: GR/G6PDH de la 1,89 la 2,94; GR/GST de la 0,41 la 0,54; GR/GGT de la 4,83 la 8,70; GR/GSH de la 333,0 la 454,0; iar în salivă: GR/G6PDH de la 1,41 la 2,21; GR/GST de la 0,34 la 0,42; GR/GGT de la 1,62 la 2,59; GR/GSH de la 613,0 la 663,2 se diagnostichează hiperplazie dishormonală a glandei mamare, iar în cazul în care în plasmă se determină: GR/G6PDH de la 0,84 la 1,89; GR/GST de la 0,29 la 0,41; GR/GGT de la 0,96 la 4,83; GR/GSH de la 212,0 la 333,0; iar în salivă: GR/G6PDH de la 0,61 la 1,41; GR/GST de la 0,26 la 0,34; GR/GGT de la 0,65 la 1,62; GR/GSH de la 562,8 la 613,0 se diagnostichează cancer al glandei mamare.
MDA20080082A 2008-03-21 2008-03-21 Metodă de diagnostic diferenţiat al tumorilor glandei mamare MD3717G2 (ro)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDA20080082A MD3717G2 (ro) 2008-03-21 2008-03-21 Metodă de diagnostic diferenţiat al tumorilor glandei mamare

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20080082A MD3717G2 (ro) 2008-03-21 2008-03-21 Metodă de diagnostic diferenţiat al tumorilor glandei mamare

Publications (2)

Publication Number Publication Date
MD3717F1 MD3717F1 (ro) 2008-10-31
MD3717G2 true MD3717G2 (ro) 2009-05-31

Family

ID=40030517

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20080082A MD3717G2 (ro) 2008-03-21 2008-03-21 Metodă de diagnostic diferenţiat al tumorilor glandei mamare

Country Status (1)

Country Link
MD (1) MD3717G2 (ro)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD492Z (ro) * 2011-08-17 2012-10-31 Лорена МЕДНИКОВ Metodă de determinare a răspândirii cancerului gastric de tip intestinal

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU873504A1 (ru) * 1972-10-31 1982-04-30 Ростовский научно-исследовательский онкологический институт Способ диагностики рака молочной железы
SU683049A1 (ru) * 1977-04-19 1982-11-30 Латвийский Научно-Исследовательский Институт Экспериментальной И Клинической Медицины Способ диагностики рака молочной железы
SU919178A1 (ru) * 1980-10-10 1988-02-07 Институт Проблем Передачи Информации Ан Ссср Способ рентгенодиагностики рака молочной железы
SU1114004A1 (ru) * 1981-12-29 1988-06-07 1-Й Ленинградский Медицинский Институт Им.Акад.Н.П.Павлова Способ диагностики степени малигнизации при фиброзно-кистозной мастопатии
SU1349498A1 (ru) * 1984-04-28 1991-08-30 Одесский Медицинский Институт Им.Н.И.Пирогова Способ диагностики метастазов рака молочной железы в лимфоузлы

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU873504A1 (ru) * 1972-10-31 1982-04-30 Ростовский научно-исследовательский онкологический институт Способ диагностики рака молочной железы
SU683049A1 (ru) * 1977-04-19 1982-11-30 Латвийский Научно-Исследовательский Институт Экспериментальной И Клинической Медицины Способ диагностики рака молочной железы
SU919178A1 (ru) * 1980-10-10 1988-02-07 Институт Проблем Передачи Информации Ан Ссср Способ рентгенодиагностики рака молочной железы
SU1114004A1 (ru) * 1981-12-29 1988-06-07 1-Й Ленинградский Медицинский Институт Им.Акад.Н.П.Павлова Способ диагностики степени малигнизации при фиброзно-кистозной мастопатии
SU1349498A1 (ru) * 1984-04-28 1991-08-30 Одесский Медицинский Институт Им.Н.И.Пирогова Способ диагностики метастазов рака молочной железы в лимфоузлы

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Kumaraguruparan R., Subapriya R., Kabalimoorthy J., Nagini S. Antioxidant profile in the circulation of patients with fibroadenoma and adenocarcinoma of the breast. Clin. Biochem., 2002, 35(4), p. 275-279 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD492Z (ro) * 2011-08-17 2012-10-31 Лорена МЕДНИКОВ Metodă de determinare a răspândirii cancerului gastric de tip intestinal

Also Published As

Publication number Publication date
MD3717F1 (ro) 2008-10-31

Similar Documents

Publication Publication Date Title
MX345056B (es) Diagnóstico y tratamiento de deficiencia de sulfatasa múltiple y otras deficiencias de sulfatasa.
EA201200217A1 (ru) Рнк с комбинацией из немодифицированных и модифицированных нуклеотидов для экспрессии белков
MA32872B1 (fr) Traitement du diabete chez des patients dont la regulation glycemique est insuffisante malgre une therapie par un medicament antidiabetique oralou non oral
WO2012045905A3 (es) Método para el diagnóstico, pronóstico y tratamiento de la metástasis de cáncer de mama
DK1893196T3 (da) Diarylhydantoin-forbindelse
MX2010014233A (es) Compuestos quimicos 251.
NO20083062L (no) Humane monoklonale antistoffer mot fukosyl-GM1 og fremgangsmater for anvendelse av anti-fukosyl-GM1
WO2011106300A3 (en) Anti-angiogenesis therapy for the treatment of ovarian cancer
WO2008033562A3 (en) Kinase inhibitor compounds
AU2009236219A8 (en) Silencing of CSN5 gene expression using interfering RNA
WO2008066784A3 (en) Expression of foxp3 by cancer cells
WO2009019370A3 (fr) Procede de dosage de l'apolipoproteine aii pour le diagnostic in vitro du cancer colorectal
UA92348C2 (en) 17b-HSD1 AND STS INHIBITORS
MY148276A (en) Long-term feed- elderly
EA200701390A1 (ru) Способ получения легкодоступного клеточного материала из пуповинной крови и композиция на его основе
TW200801032A (en) Azaheterocyclyl derivatives of androstanes and androstenes as medicaments for cardiovascular disorders
WO2006133361A3 (en) Use of gene expression profiling to predict survival in cancer patient
Choi et al. Druggable metabolic vulnerabilities are exposed and masked during progression to castration resistant prostate cancer
DK3295954T3 (da) Middel til anvendelse ved intestinal fruktoseintolerans
Hao et al. The role of protein post-translational modifications in prostate cancer
MD3717G2 (ro) Metodă de diagnostic diferenţiat al tumorilor glandei mamare
EP1984013A4 (en) CST II MODIFICATIONS FOR INCREASED PROTEIN EXPRESSION
MX2007011493A (es) Modalidades antiinflamatorias.
MX2009005550A (es) Inhibidores de fosfatasa de proteina tirosina para la promocion de la hipertrofia cardiaca fisiologica.
Di Leandro et al. Cystamine restores GSTA3 levels in Vanin-1 null mice

Legal Events

Date Code Title Description
FG4A Patent for invention issued
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees